| Trial ID: | L0158 |
| Source ID: | NCT01842282
|
| Associated Drug: |
Amlexanox
|
| Title: |
Amlexanox for Type 2 Diabetes and Obesity
|
| Acronym: |
--
|
| Status: |
Suspended
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Diabetes Mellitus Type 2|Non Alcoholic Fatty Liver Disease|Obesity
|
| Interventions: |
Drug: Amlexanox
|
| Outcome Measures: |
HbA1c|hepatic steatosis by MRI|Weight
|
| Sponsor/Collaborators: |
University of Michigan
|
| Gender: |
All
|
| Age: |
18 Years to 59 Years ?? (Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
15
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
July 19, 2013
|
| Completion Date: |
July 2024
|
| Results First Posted: |
--
|
| Last Update Posted: |
January 12, 2022
|
| Locations: |
University of Michigan, Ann Arbor, Michigan, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01842282
|
